Top Markets
#1 BOOK OF MEME BOOK OF MEME +27.51%
#2 XPIN Network XPIN Network +22.15%
#3 EXOD EXOD +22.08%
#4 Verus Coin Verus Coin +20.42%
#5 Ore Ore +20.30%
#6 SSV Network SSV Network +20.00%
#7 Geodnet Geodnet +17.88%
#8 Neiro Neiro +17.80%
#9 Bitcoin Cash Bitcoin Cash +17.70%
#10 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +17.45%
Coin of the day
BOOK OF MEME BOOK OF MEME
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Sirnaomics Ltd. Sirnaomics Ltd.

Sirnaomics Ltd.

2257
Rang in aandelen #25196
Sirnaomics Ltd. is an RNA therapeutics biopharmaceutical company, founded in... Sirnaomics Ltd. is an RNA therapeutics biopharmaceutical company, founded in 2007 and headquartered in Gaithersburg, Maryland. The company is dedicated to identifying and developing innovative therapeutic compounds aimed at addressing significant medical needs across the United States and the People's Republic of China. Its leading pipeline assets include STP705, which is being investigated for conditions such as cutaneous squamous cell carcinoma in situ, basal cell carcinoma, various liver-related cancers (cholangiocarcinoma, hepatocellular carcinoma, liver metastases), as well as for keloid scar remodeling, hypertrophic scarring, and fat sculpting. Another prominent candidate, STP707, is designed to treat cholangiocarcinoma, hepatocellular carcinoma, liver metastases, metastatic cutaneous squamous cell carcinoma, non-small cell lung cancer, and both liver and lung fibrosis. Beyond these lead programs, Sirnaomics is advancing STP355 for a range of cancers; STP369 for head and neck/bladder cancers; STP779 for liver, lung, and pancreatic cancers; and STP902 for breast cancer. The company's portfolio also extends to infectious diseases with STP702 for influenza, STP908 for COVID-19, the RIM730 COVID-19 vaccine, and STP909 for HPV/cervical cancer. Furthermore, its developmental pipeline encompasses STP122G for thrombotic disorders, STP125G for hypertriglyceridemia, STP144G for complement-mediated ailments, STP133G for cardiometabolic conditions, and STP155G for hepatitis B virus.
Aandeelprijs
$0.48164226
Marktkapitalisatie
$52.45M
Verandering (1 dag)
-3.46%
Verandering (1 jaar)
-61.91%
Land
US
Handel Sirnaomics Ltd. (2257)

Categorie

Healthcare
Dividendgeschiedenis van Sirnaomics Ltd. (2257)
Sirnaomics Ltd. (aandelsymbool: 2257) heeft in totaal 0 dividenduitkeringen gedaan.
De som van alle dividenden (aangepast voor aandelensplitsingen) is: 0.00
Dividendrendement (TTM): 0
Dividendbetalingen voor Sirnaomics Ltd. (2257) van 2026 tot 2026
Jaarlijkse dividendbetalingen
Jaar Dividend (aangepast voor aandelensplitsingen) Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Lijst van alle dividendbetalingen
Jaar Dividend Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendbetalingen voor vergelijkbare bedrijven of concurrenten
Bedrijf Aantal dividendbetalingen Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US